Global Self-Injection Market Opportunities and Strategies

Dublin, July 1, 2024 (GLOBE NEWSWIRE) — The “Self-Injections Global Market Opportunities and Strategies to 2033” report has been added to Research and Marketing.com offering.

The global self-injectable market reached a value of nearly $9.3 billion in 2023, growing at a compound annual growth rate (CAGR) of 6.7% since 2018. The market is expected to grow from $9.3 billion in 2023 . to $13.2 billion in 2028 at a rate of 7.2%. The market is expected to grow at a compound annual growth rate of 7.9% from 2028 and reach $19.2 billion by 2033.

Growth in the historical period was driven by patient preferences for home care services, the shift to personalized medicine, and the rise of telehealth and telemedicine. Factors that negatively impacted growth in the historical period included a lack of patient education and training.

In the future, this growth will be driven by the rise in chronic diseases, rising healthcare expenditures, an aging population, and strong economic growth. Factors that may hinder the growth of the self-injection market in the future include regulatory hurdles and needle phobia and fear.

The self-injection market is segmented by type into devices and formulations. The devices market was the largest segment of the self-injection market by type, accounting for 65.7% or $6.1 billion of the total in 2023. Going forward, the formulations segment is expected to be the fastest growing segment in the self-injection market by type, at a CAGR of 7.8% in 2023–2028.

The self-injection market is segmented by application into cancer, autoimmune diseases, hormonal disorders, pain management, and other applications. The hormonal disorders market was the largest segment of the self-injection market segmented by application, accounting for 39.3% or $3.7 billion of the total in 2023. Going forward, the pain management segment is expected to be the fastest growing segment in the self-injection market segmented by application, with a compound annual growth rate (CAGR) of 8.7% during 2023-2028.

The self-injection market is segmented based on route of administration to the skin, circulatory system or musculoskeletal system, organs, and central nervous system. The skin market was the largest segment of the self-injection market by route of administration, accounting for 64.1% or $6 billion of the total in 2023. Going forward, the skin segment is expected to be the fastest growing segment in the self-injection industry. The injection market is segmented by route of administration, with a CAGR of 7.4% during 2023-2028.

The self-injection market is segmented by dosage into single dose and multiple dose. The single-dose market was the largest segment of the self-injection market by dose, accounting for 63.5% or $5.9 billion of the total in 2023. The multi-dose segment is expected to be the fastest-growing segment in the self-injection industry going forward. The injection market is segmented by dose at a CAGR of 7.7% during 2023-2028.

The largest region in the self-injection market was North America, accounting for 34.5% or $3.21 billion in total in 2023. This was followed by Asia-Pacific, Western Europe, and then other regions. Going forward, the fastest growing regions in the self-injection market will be Asia-Pacific and North America, where the growth will be at a CAGR of 8.2% and 7.5%, respectively. This will be followed by Western Europe and South America, where the markets are expected to grow at a CAGR of 7% and 5.6%, respectively.

The global self-injection market is quite concentrated, with large players operating there. The top ten competitors in the market accounted for up to 33% of the total market in 2022. Pfizer Inc. was the largest competitor with 8% market share, followed by Becton Dickinson and Company with 5.3%, Ypsomed Holding AG with 5.1%, Eli Lilly and Company with 4.1%, Merck & Co. Inc. with 3%, Bristol-Myers Squibb Company with 1.9%, Insulet Corporation with 1.8%, Bayer AG with 1.7%, Halozyme Therapeutics, Inc. with 1.1% and Abbvie Inc with 1%.

The largest opportunities in the self-injection market segmented by type will be in the device segment, which will gain $2.4 billion in global annual sales by 2028. The largest opportunities in the self-injection market segmented by application will be in the hormonal disruption segment, which will gain $1.4 billion in global annual sales by 2028. The largest opportunities in the self-injection market segmented by distribution channel will appear in the chemical segment, which will gain USD 1.5 billion in global annual sales by 2028. The largest opportunities in the self-injection market segmented by route of administration will appear in the skin segment, which will gain USD 2.6 billion in global annual sales by 2028. The largest opportunities in the self-injection market segmented by dosage will be in the single-dose segment, which will reach $2.3 billion in global annual sales by 2028. The size of the self-injection market will grow most in the US, reaching USD 1.2 billion.

The strategies adopted by players in the self-financing market include focusing on strengthening business operations through new product introductions, increasing operational capabilities through new product development and validation, and expanding business opportunities through strategic partnerships.

The report covers market characteristics; size and height; segmentation; regional and national division; competitive landscape; market shares; trends and strategies for this market. It tracks the market history and forecasts the market growth by geographic region. It places the market in the context of the broader stand-alone injection market; and compares it with other markets.

Markets served:

By type: Devices; Formulas
By use: cancer; Autoimmune diseases; Hormonal disorders; Pain Management; Other applications
By distribution channels: Hospital pharmacies; clinics; Pharmacy; Online pharmacies
Route of administration: Skin; Circulatory or musculoskeletal system; Organs; Central nervous system
By dosage: single dose; multiple doses

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years of historical data and ten years of projected data.

Data: Relation of market size and growth to related markets; GDP proportions; per capita expenditure; comparison of self-injection rates.

Data segmentation: National and regional historical data and forecasts; competitors’ market share; market segments.

Key Features:

Report attribute	Details
number of pages	289
Forecast period	2023-2033
Estimated market value (USD) in 2023	$9.3 billion
Projected market value (USD) until 2033	$19.2 billion
Compound Annual Growth Rate	7.5%
Regions covered	Global

Main topics:

1 Summary

2 Table of Contents

3 List of tables

4 List of drawings

5 Report structure

6 Market Characteristics
6.1 General market definition
6.2 Summary
6.3 Definition and segmentation of the self-injectable market
6.4 Market segmentation by type
6.4.1 Devices
6.4.2 Recipes
6.5 Market segmentation by route of administration
6.5.1 Skin
6.5.2 Circulatory or musculoskeletal system
6.5.3 Organs
6.5.4 Central nervous system
6.6 Market segmentation by dosage
6.6.1 Single dose
6.6.2 Multiple dose
6.7 Market segmentation by application
6.7.1 Cancer
6.7.2 Autoimmune diseases
6.7.3 Hormonal disorders
6.7.4 Pain management
6.7.5 Other applications
6.8 Market segmentation by distribution channels
6.8.1 Hospital pharmacies
6.8.2 Clinics
6.8.3 Chemists
6.8.4 Online pharmacies

7 Major Market Trends
7.1 Inserting the single-dose pre-filled pen for correct administration
7.2 Focus on improving the user experience by combining self-injection devices with the application
7.3 Strategic partnerships and cooperation between market participants
7.4 Expansion of production facilities to expand the portfolio

8 Own Injection Market – Macroeconomic Scenario
8.1 Impact of COVID-19 on the self-injection market
8.2 The impact of the war in Ukraine on the self-injection market
8.3 Impact of high inflation on the self-injection market

9 Global market size and growth
9.1 Market Size
9.2 Historical market growth, 2018-2023, value (USD million)
9.3 Market Growth Forecast, 2023-2028, 2033F Value (USD Million)

10 Global Self-Injection Market Segmentation
10.1 Global Self-Injectable Market, Segmented by Type, Historical and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)
10.2 Global Self-Injection Market, Segmentation by Application, Historical Data and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)
10.3 Global Self-Injectable Market, Segmentation by Distribution Channel, Historical Data and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)
10.4 Global Self-Injection Market, Segmentation by Route of Administration, Historical Data and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)
10.5 Global Self-Injectable Market, Dose Segmentation, Historical Data and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)

11 Self-injection market, regional and national analysis
11.1 Global Self-Injection Market by Region, Historical Data and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)
11.2 Global Self-Injection Market by Country, Historical and Forecast, 2018-2023, 2028F, 2033F, Value (USD Million)

12 Asia Pacific Market

13 Western European market

14 Eastern European market

15 North American market

16 South American Market

17 Middle East Market

18 African Market

19 Competitive Landscape and Company Profiles
19.1 Company profiles
19.2 Pfizer Inc
19.3 Becton, Dickinson and co
19.4 Ypsomed Holding
19.5 Eli Lilly and Co.
19.6 Merck & Co., Inc.

20 Competitive benchmarking

21 Competitive panel

22 Key Mergers and Acquisitions
22.1 LTS took over the activities of Eitan Medical in the field of portable injection devices
22.2 Dr Reddy’s Injectables Portfolio Acquired From Eton Pharma
22.3 Halozyme acquired Antares Pharma
22.4 Sulzer Ltd. Takeover of Haselmeier

23 Opportunities and Strategies
23.1 Global Self-Injection Market in 2028 – Countries Offering the Most New Opportunities
23.2 Global self-injection market in 2028 – segments offering the most new opportunities
23.3 Global Self-Injection Market 2028 – Growth Strategies
23.3.1 Strategies based on market trends
23.3.2 Competitive strategies

24 Self-injection Market, Conclusions and Recommendations

For more information on this report, please visit https://www.researchandmarkets.com/r/802xq4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Global self-injection market